Health officials have reported that a highly contagious skin infection, scabies, continues to impact a significant number of children in Fiji, primarily due to close contact in homes and schools. Recent research conducted by dermatologist Dr. Metuisela Tuicakau revealed that approximately 30 percent of patients visiting health facilities were seeking treatment for scabies, highlighting the prevalence of this neglected tropical disease.
Ivermectin, a medication recognized worldwide for its effectiveness against scabies, is now available in Fiji. Dr. Tuicakau noted that the drug is part of the country’s essential medicines list and is provided free of charge to the public. This accessibility aims to ensure that everyone, especially children affected by the infection, can receive timely treatment. Additionally, treatment creams are available at health facilities to aid in recovery.
Scabies is among several neglected tropical diseases affecting the Fijian population, alongside lymphatic filariasis, trachoma, leprosy, and yaws. While Fiji has successfully eliminated trachoma as a public health issue, health authorities emphasize the ongoing need to control other infectious diseases, including scabies. Dr. Tuicakau urges parents to be vigilant and seek early treatment if their children exhibit any signs of skin problems, thus helping to mitigate the spread of this infection.
The proactive measures being taken in Fiji reflect a commitment to improving public health and addressing these overlooked diseases. By making effective treatments such as ivermectin readily available, there is hope for better control of scabies and other neglected tropical diseases in the region.
Leave a comment